Physician
Alfredo Garcia MD & Liiliana Caceres MD
Alfredo Garcia MD & Liiliana Caceres MD was paid $605K by Medicaid between Jan 2018 and Sep 2024, across 63 billing codes. Its largest line is 99391, Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) — 20% of everything it billed.
33Billing provider infoALFREDO GARCIA MD & LIILIANA CACERES MD
MADERA, CA 93637
MADERA, CA 93637
33aNPI1225248537assigned 05/23/2007
33bProvider typePediatrics Physician
28Total paid$605K
24GClaims177,310
24DCodes billed63
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#198 of 1,490
Median peer was paid$15K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,622 | $57K | |
| 2019 | 23,345 | $77K | |
| 2020 | 20,899 | $79K | |
| 2021 | 25,715 | $83K | |
| 2022 | 35,099 | $85K | |
| 2023 | 39,613 | $143K | |
| 2024incomplete | 17,017 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 20% | 5,309 | 5,201 | $123K |
| 99381 | 18% | 1,222 | 1,206 | $107K | |
| 96156 | 12% | 10,619 | 10,498 | $75K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 13,284 | 12,336 | $69K |
| 90697 | 9.7% | 1,918 | 1,902 | $59K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.0% | 4,206 | 4,023 | $24K |
| 99460 | 3.3% | 2,050 | 2,043 | $20K | |
| 97803 | 2.5% | 7,685 | 7,634 | $15K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 5,703 | 5,653 | $14K |
| 99462 | 1.9% | 2,049 | 1,617 | $11K | |
| 97802 | 1.8% | 521 | 515 | $11K | |
| 90680 | 1.7% | 3,765 | 3,744 | $11K |
51 more codes
| 90670 | 1.2% | 3,978 | $7K | |
| 99232 | Hospital visit by a doctor, follow-up day | 1.1% | 1,296 | $7K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.1% | 793 | $7K |
| 90698 | 1.1% | 2,379 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,436 | $6K |
| 87428 | <1% | 1,121 | $5K | |
| 90744 | <1% | 1,567 | $5K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,394 | $4K |
| 90671 | <1% | 1,509 | $3K | |
| G9920 | Screening performed and negative | <1% | 6,775 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,638 | $2K |
| 92551 | <1% | 7,549 | $2K | |
| 90686 | <1% | 6,012 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 841 | $884.38 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 42 | $838.38 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,164 | $767.40 |
| D1206 | Topical application of fluoride varnish | <1% | 1,394 | $766.26 |
| 85018 | <1% | 14,639 | $609.16 | |
| 94760 | <1% | 3,795 | $459.29 | |
| 90633 | <1% | 1,917 | $447.75 | |
| 83655 | <1% | 1,591 | $398.97 | |
| 90707 | <1% | 1,788 | $369.00 | |
| 90716 | <1% | 1,772 | $369.00 | |
| 90657 | <1% | 580 | $261.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,110 | $229.52 |
| 81002 | <1% | 7,147 | $221.66 | |
| 90700 | <1% | 854 | $211.50 | |
| 99188 | <1% | 249 | $156.28 | |
| 90658 | <1% | 1,116 | $153.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 265 | $151.69 |
| 90648 | <1% | 645 | $108.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $70.66 |
| 94664 | <1% | 101 | $55.74 | |
| 86580 | <1% | 1,359 | $53.65 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 4,143 | $43.62 |
| 87807 | <1% | 45 | $40.71 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 10,078 | $30.51 |
| 90696 | <1% | 339 | $27.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 744 | $24.63 |
| 96127 | <1% | 1,056 | $19.04 | |
| 90651 | <1% | 128 | $18.00 | |
| 90734 | <1% | 80 | $9.00 | |
| 90619 | <1% | 68 | $9.00 | |
| 99173 | <1% | 7,275 | $2.51 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 189 | $1.32 |
| 90715 | 0% | 38 | $0.00 | |
| 90649 | 0% | 125 | $0.00 | |
| 69210 | 0% | 77 | $0.00 | |
| 90474 | 0% | 1,670 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 6,935 | $0.00 |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 0% | 160 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCACERES, LILIANA (PARTNER)